MenstruationNCT07561905
Tampon Safety-in-Use Study
A study testing Tampon A in people with Menstruation, run by Kimberly-Clark Corporation at 1 site in United States.
Trial summary
The goal of this clinical trial is to confirm the safety of a tampon in healthy female volunteers. Participants will use the study tampons as they normally would for one menstrual cycle. Gynecological exams will be conducted before and after the menstrual cycle. Read more about this study
- Who is it for?
- Ages 18 to 49 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Menstruation
- What is being tested?
- Tampon A
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 62 participants
- Where
- 1 siteUnited States
- Study dates
- 12 May 2026to 16 Sep 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 49 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Willing and able to read and provide written informed consent.
- Female in good general health, age 18-49 (inclusive).
- History of regular menstrual cycles during the previous 3months lasting approximately 21-35 days, including at least 4 days of menstruation, and expecting to menstruate during the study period.
- History of use of applicator tampons within the past 12 months without discomfort.
- Tracks menstruation and be able to confidently predict onset of menstruation
- Normally use at least 6 tampons for protection during menstruation.
Show all 9Show fewer
- Normally uses regular, super, and/or super plus absorbency tampons for menstrual protection.
- Agrees to the conduct of all study procedures, including gynecological exams and agrees to follow all study instructions and return for scheduled appointments.
- Has used an acceptable form of birth control for at least one month prior to enrollment and for the duration of the study.
Who cannot join
- Pregnant, lactating or is trying to become pregnant.
- Less than six (6) weeks post-partum.
- Has a menstrual abnormality (such as oligomenorrhea or amenorrhea).
- Has a known allergy or sensitivity to components of the investigational products
- Any other medical condition or history, as determined by the Investigator that could compromise the study results or subject safety.
Trial locations and contacts
1 site in 1 country.
United States1 site
Princeton Consumer Research
St. Petersburg, Florida, 33702
About this study
Official title: An Open-Label Applicator Tampon Safety-in-Use Study
The goal of this clinical trial is to confirm the safety of a tampon in healthy female volunteers. Participants will use the study tampons as they normally would for one menstrual cycle. Gynecological exams will be conducted before and after the menstrual cycle.
- Conditions
- Menstruation
- Being tested
- Tampon A
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Tampon ADevice
Commercially available tampons in regular, super, and super plus absorbencies
| Study group | Role | What they receive |
|---|---|---|
| Test Tampon | Experimental | Not described Receives: Device: Tampon A |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of Tampon Related Adverse Events
Frequency and severity of tampon related adverse events
Measured: From enrollment to 7 days post last visit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 May 2026
- Study start12 May 2026
- Primary completion15 Sep 2026
- Study completion16 Sep 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MenstruationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 62 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kimberly-Clark Corporation
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07561905
- Sponsor's protocol ID
- CNS-2026-0003
- Status last verified
- Sep 2026
- First submitted
- 24 Apr 2026
- Last updated
- 23 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Open-Label Applicator Tampon Safety-in-Use Study
- ClinicalTrials.gov ID
- NCT07561905
- Acronym / sponsor ID
- CNS-2026-0003
- Conditions
- Menstruation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 62 participants (actual)
- Lead sponsor
- Kimberly-Clark CorporationIndustry (pharma, biotech, devices)
- Study start
- 12 May 2026 (actual)
- Primary completion
- 15 Sep 2026 (actual)
- Study completion
- 16 Sep 2026 (actual)
- First posted
- 1 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to confirm the safety of a tampon in healthy female volunteers. Participants will use the study tampons as they normally would for one menstrual cycle. Gynecological exams will be conducted before and after the menstrual cycle.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Test Tampon | Experimental | Device: Tampon A |
Who may qualify
- Ages
- 18 to 49 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (9 listed)
- Willing and able to read and provide written informed consent.
- Female in good general health, age 18-49 (inclusive).
- History of regular menstrual cycles during the previous 3months lasting approximately 21-35 days, including at least 4 days of menstruation, and expecting to menstruate during the study period.
- History of use of applicator tampons within the past 12 months without discomfort.
- Tracks menstruation and be able to confidently predict onset of menstruation
Key exclusion criteria (5 listed)
- Pregnant, lactating or is trying to become pregnant.
- Less than six (6) weeks post-partum.
- Has a menstrual abnormality (such as oligomenorrhea or amenorrhea).
- Has a known allergy or sensitivity to components of the investigational products
- Any other medical condition or history, as determined by the Investigator that could compromise the study results or subject safety.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Tampon ACommercially available tampons in regular, super, and super plus absorbencies | Device | Test Tampon |
Primary outcome
Incidence of Tampon Related Adverse Events
Time frame: From enrollment to 7 days post last visit
Frequency and severity of tampon related adverse events
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Menstruation
Active, not recruitingObservational study
Factors Influencing Fertility or Pregnancy Health
Menstrual Cycles, Conception
RecruitingPhase 4
Period Pills for Menstrual Regulation: A New Reproductive Health Option
Menstrual Regulation, Menstrual Health Intervention
Active, not recruiting
Mindfulness-Based Education For Women With Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS), Menstrual Symptoms
RecruitingObservational study
Inherited Reproductive Disorders
Genetic Disorder, Infertility
Not yet recruiting
The Effect of a Ginger Formula on Menstrual Health vs a Placebo
Painful Menstruation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Tampon A in people with Menstruation, run by Kimberly-Clark Corporation at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of Tampon Related Adverse Events (time frame: From enrollment to 7 days post last visit). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2026.